Elodie Roger

9PUBLICATIONS
57CO-AUTHORS
Tissue engineeringMolecular targetsLiquid biopsiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 11, 2026
ATM Deficiency Induces TGFβ-Mediated Stromal Programming in Pancreatic Cancer.

|Oct 28, 2025
DKK3 Initially Preserves Acinar Integrity Through MEK-Fos Signaling, but Later Switches to an Oncogenic Role in Pancreatic Cancer.

Dharini Srinivasan, Elodie Roger, Lukas Perkhofer

|Aug 18, 2025
Homologous Repair-Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic Strategy.

Alica K Beutel, Christopher J Halbrook, Menar Ekizce

|Feb 03, 2022
Organoids at the PUB: The Porcine Urinary Bladder Serves as a Pancreatic Niche for Advanced Cancer Modeling.

Michael Karl Melzer, Markus Breunig, Frank Arnold

|Jun 02, 2021
A Prospective Feasibility Trial to Challenge Patient-Derived Pancreatic Cancer Organoids in Predicting Treatment Response.

Alica K Beutel, Lena Schütte, Jeanette Scheible

|Feb 03, 2021
RINT1 Regulates SUMOylation and the DNA Damage Response to Preserve Cellular Homeostasis in Pancreatic Cancer.

Frank Arnold, Johann Gout, Heike Wiese

Pageof 2

Frequent Collaborators

9 joint publications

Alexander Kleger

8 joint publications

Johann Gout

5 joint publications

Lukas Perkhofer

5 joint publications

Frank Arnold